Dysfunction of the neuronal RNA binding protein RBFOX1 has been linked to epilepsy and autism spectrum disorders. Rbfox1 loss in mice leads to neuronal hyper-excitability and seizures, but the physiological basis for this is unknown. We identify the vSNARE protein Vamp1 as a major Rbfox1 target. Vamp1 is strongly downregulated in Rbfox1 Nes-cKO mice due to loss of 3 0 UTR binding by RBFOX1. Cytoplasmic Rbfox1 stimulates Vamp1 expression in part by blocking microRNA-9. We find that Vamp1 is specifically expressed in inhibitory neurons, and that both Vamp1 knockdown and Rbfox1 loss lead to decreased inhibitory synaptic transmission and E/I imbalance. Re-expression of Vamp1 selectively within interneurons rescues the electrophysiological changes in the Rbfox1 cKO, indicating that Vamp1 loss is a major contributor to the Rbfox1 Nes-cKO phenotype. The regulation of interneuronspecific Vamp1 by Rbfox1 provides a paradigm for broadly expressed RNA-binding proteins performing specialized functions in defined neuronal subtypes.
SUMMARY
Dysfunction of the neuronal RNA binding protein RBFOX1 has been linked to epilepsy and autism spectrum disorders. Rbfox1 loss in mice leads to neuronal hyper-excitability and seizures, but the physiological basis for this is unknown. We identify the vSNARE protein Vamp1 as a major Rbfox1 target. Vamp1 is strongly downregulated in Rbfox1 Nes-cKO mice due to loss of 3 0 UTR binding by RBFOX1. Cytoplasmic Rbfox1 stimulates Vamp1 expression in part by blocking microRNA-9. We find that Vamp1 is specifically expressed in inhibitory neurons, and that both Vamp1 knockdown and Rbfox1 loss lead to decreased inhibitory synaptic transmission and E/I imbalance. Re-expression of Vamp1 selectively within interneurons rescues the electrophysiological changes in the Rbfox1 cKO, indicating that Vamp1 loss is a major contributor to the Rbfox1 Nes-cKO phenotype. The regulation of interneuronspecific Vamp1 by Rbfox1 provides a paradigm for broadly expressed RNA-binding proteins performing specialized functions in defined neuronal subtypes.
INTRODUCTION
The importance of post-transcriptional gene regulation in neuronal function has been underscored by the many RNA binding proteins (RBPs) linked to neurodevelopmental and neurologic disorders (Chabot and Shkreta, 2016; Licatalosi and Darnell, 2006; Poulos et al., 2011; Srikantan and Gorospe, 2012) . RBPs function in many critical cellular processes including alternative splicing, mRNA decay, translation, and subcellular mRNA localization. However, an understanding of how RBPs determine specific physiological changes in particular cell types has not been achieved. These RBPs are often broadly expressed throughout the brain and present pleiotropic phenotypes in knockout mice, reflecting many splicing and gene expression changes. The functions of these extensive post-transcriptional regulatory programs and their roles in specific neuronal cell types and circuits are still largely unexplored.
The Rbfox family of brain-enriched RBPs is widely studied as regulators of alternative splicing. The three mammalian family members-Rbfox1, Rbfox2, and Rbfox3-each has a highly conserved RNA recognition motif (RRM) that binds the sequence (U)GCAUG (Conboy, 2017; Jin et al., 2003; Kuroyanagi, 2009; Ponthier et al., 2006; Underwood et al., 2005) . In regulating splicing in the nucleus, Rbfox proteins bind to pre-mRNAs within a large assembly of splicing regulators Ying et al., 2017) . Rbfox transcripts are themselves alternatively spliced to create cytoplasmic isoforms that bind within 3 0 UTR sequences to regulate translation (Carreira-Rosario et al., 2016; Lee et al., 2016; Nakahata and Kawamoto, 2005) . The ratio of nuclear to cytoplasmic Rbfox varies between cells and can be dynamically regulated by membrane depolarization (Lee et al., 2009) .
Previous work found that pan-neuronal Rbfox1 loxP/loxP ; NestinCre +/À knockout mice (Rbfox1 Nes-cKO) were susceptible to spontaneous and induced seizures (Gehman et al., 2011) . Extracellular recordings in the dentate gyrus of the hippocampus found that low intensity presynaptic fiber stimulation elicited larger field excitatory postsynaptic potentials (EPSPs) in the cKO compared to wild-type. Spine density and expression levels of synaptic proteins such as Synapsin-I and PSD-95 were unchanged, suggesting that a change in synaptic function rather than synapse number was responsible for neuronal hyperexcitability in the Rbfox1 Nes-cKO brain. Whole-transcriptome profiling by microarray and RNA sequencing (RNA-seq) identified multiple gene expression and alternative splicing changes in the (D and E) Vamp1 mRNA and protein levels are reduced in the Rbfox1 Nes-cKO forebrain but not in cerebellum.
(legend continued on next page) knockout mice, but these were assayed in whole brain and difficult to relate to the electrophysiological results (Gehman et al., 2011; Lovci et al., 2013; Weyn-Vanhentenryck et al., 2014) . Recent work demonstrated a role for cytoplasmic Rbfox1 in promoting mRNA stability and/or translation by binding the 3 0 UTRs of target transcripts (Carreira-Rosario et al., 2016; Lee et al., 2016) . This cytoplasmic portion of the Rbfox1 regulatory program was enriched for many key neuronal functions such as the calcium signaling pathway, as well as regulatory modules controlling cortical development and modules altered in autism spectrum disorder (ASD) . Interestingly, this cytoplasmic program largely affected transcripts different from those regulated by the splicing program. Thus, loss of cytoplasmic Rbfox1 likely also contributes to the pathophysiology of the Rbfox1 Nes-cKO in parallel with the splicing changes controlled by the nuclear protein. However, the specific contribution of cytoplasmic Rbfox1 to altered neuronal excitability remains unexplored. Here, we examine the changes in gene expression and electrophysiology controlled by Rbfox1, specifically in the hippocampus. We identify the vSNARE Vamp1 as a major target of cytoplasmic Rbfox1 that plays a critical role in inhibitory synaptic transmission. Our results demonstrate how regulation of Vamp1 mRNA abundance by cytoplasmic Rbfox1 controls synaptic function in a specific neuronal cell type and contributes to the greater network defects in the Rbfox1 NescKO brain.
RESULTS

Vamp1 Is a Direct Rbfox1 Target
To obtain a more refined view of posttranscriptional regulation specifically by Rbfox1 and specifically in the hippocampus, we performed RNA-seq on adult (P60-70) hippocampi isolated from Rbfox1 Nes-cKO and wild-type littermates (n = 3 each genotype). We identified significant changes in both alternative splicing and overall mRNA abundance, consistent with the dual role of Rbfox1 in regulation of alternative splicing and mRNA stability. As seen previously, Rbfox1-dependent gene expression changes did not significantly overlap with splicing changes (19 genes changing in both overall mRNA abundance and exon usage; Figure S1A ; Table S3 ) . The gene expression changes identified in the cKO hippocampus (1,034 genes) partially overlapped (183 genes) with previously identified cytoplasmic Rbfox1 targets in cultured neurons (774 genes) . The differences between these RNA-seq datasets are likely due both to gene expression changes between tissue and in vitro culture, to differences between prolonged versus acute loss of Rbfox, and to the additional depletion of Rbfox3 in the previous study.
Focusing on the 1,034 differentially expressed (DE) genes detected in the hippocampus, we examined the overlap of our target transcripts with Rbfox1 individual nucleotide resolution cross-linking immunoprecipitation (iCLIP) datasets from the soluble nucleoplasmic fraction of adult mouse forebrain and from the cytoplasmic fraction of cultured primary neurons . We filtered the target list by requiring DE genes to contain 3 0 UTR iCLIP clusters in both the nucleoplasmic and cytoplasmic datasets, and that these clusters also contain an Rbfox motif [(U)GCAUG] within ±10 nucleotides of the edge of the cluster ( Figure 1A ). These stringent filters generated a list of 15 high confidence genes directly regulated by Rbfox1 ( Figure 1B ; Table S4 ) and include adenylyl cyclase, potassium channels, neuropeptide Y, and others. Most targets were downregulated upon Rbfox1 loss, as seen previously in cultured neurons, but four were upregulated and thus appear to be repressed by the protein. Using less stringent filters, many additional transcripts are seen to be regulated by Rbfox1 (Tables S2 and S4) .
Vamp1 (also known as Synaptobrevin1) mRNA exhibited one of the largest changes in expression, decreasing by 50% in the Rbfox1 Nes-cKO hippocampus as measured by RNA-seq and qPCR (Figures 1B and 1D) . RBFOX1 binding to the Vamp1 mRNA is restricted to the 3 0 UTR and is observed in the nucleoplasmic and cytoplasmic fractions, but not in the highmolecular-weight, chromatin-associated nuclear pellet where the Rbfox1 protein binds within introns to regulate splicing (Figure 1C ). Immunoblotting for Vamp1 in cKO and wild-type adult brains, we found that Vamp1 protein, like the mRNA, was dramatically depleted by $80% in the cKO cortex and hippocampus ( Figure 1E ). Interestingly, there was relatively little effect on Vamp1 expression in the cerebellum, where its regulation presumably involves additional factors ( Figures 1D  and 1E ). The mRNA and protein levels of the paralog Vamp2 were unchanged between Rbfox1 Nes-cKO and wild-type (Figures S1F and S1G). In the forebrain, the reduced Vamp1 mRNA and protein levels and the direct binding of RBFOX1 to the Vamp1 3 0 UTR suggest a role for cytoplasmic Rbfox1 in regulating Vamp1 expression by promoting its mRNA stability and/or translation.
The Vamp1 3 0 UTR Confers Rbfox1-Dependent Expression Despite RBFOX1 binding to the Vamp1 3 0 UTR, it was possible that the decreased Vamp1 expression in the cKO forebrain resulted from loss of nuclear Rbfox1 function or from indirect effects of Rbfox1 loss. To assess the mechanisms of Rbfox1-mediated regulation, we cultured primary hippocampal neurons from Rbfox1 Nes-cKO embryos that lack both the nuclear and cytoplasmic isoforms. Both Vamp1 mRNA and protein levels were reduced in cultured cKO neurons compared to the wildtype (Figure 2A ), similar to the reduction observed in the adult cKO hippocampus ( Figures 1D and 1E ). Using adeno-associated (D) qPCR analyses of Vamp1 mRNA from adult hippocampus, cortex, and cerebellum of wild-type and Rbfox1 Nes-cKO littermates. Vamp1 was normalized to Hprt expression and shown as a percentage of wild-type in each brain region. (E) Left, immunoblot of RBFOX1, VAMP1, and GAPDH. Right, quantification of Vamp1 protein as a percentage of wild-type expression for each brain region after normalization to GAPDH. For (D) and (E), n = 3 littermate pairs; Student's t test; **p % 0.01, ***p % 0.001; error bars, SEM. See also Figure S1 and Tables S1, S2 , S3, and S4. Figure 2A ). These results demonstrate that cytoplasmic Rbfox1 is sufficient to promote Vamp1 expression. Given the observed binding in the Vamp1 3 0 UTR ( Figure 1C ), Rbfox1 may enhance Vamp1 mRNA stability or translation.
To examine the role of the Vamp1 3 0 UTR in Rbfox1 regulation, we used the luciferase reporter system in primary hippocampal neurons ( Figure 2B ). For a reporter containing the fulllength (FL) Vamp1 3 0 UTR, Rbfox1 loss decreased expression by $50% (FL, Figures 2C and 2D) . Thus, expression from transcripts containing the Vamp1 3 0 UTR is strongly Rbfox1 dependent, with the residual expression possibly due to the presence of cytoplasmic Rbfox3 and see below) . We tested the roles of the seven Rbfox binding motifs (U)GCAUG in stimulating expression by mutating them to (U)GACGU. Mutation of the first six sites significantly reduced reporter expression (FLm1-6, Figures 2C and 2D ), while mutation of all sites virtually abolished reporter expression (FLm1-7, Figures  2C and 2D) . Notably, mutation of only the 3 0 -most Rbfox binding site reduced reporter expression as strongly as mutation of all six upstream sites (FLm7, Figures 2C and 2D ). We did not observe a significant change in expression of the FLm1-6 mutant upon loss of Rbfox1. In contrast, there was a visible, though not statistically significant, decrease in FLm7 reporter expression with loss of Rbfox1. These different responses to the loss of Rbfox1 by the mutant 3 0 UTRs may result from differences in their responses to cytoplasmic Rbfox3 . Overall, these results indicate that RBFOX1 binding to the Vamp1 3 0 UTR strongly stimulates its expression and that the 3 0 -most Rbfox binding site plays a major role in this regulation.
We noted that the 3 0 -most Rbfox binding site immediately abuts a microRNA response element (MRE) identified by TargetScan as a binding site for microRNA-9 (MiR-9 MRE, magenta; Figure 2E ) (Friedman et al., 2009; Grimson et al., 2007; Lewis et al., 2005) . The sequence encompassing these two regulatory elements shows a high degree of mammalian conservation ( Figure 2E ), indicating a likely regulatory function. We hypothesized that RBFOX1 binding to the 3 0 -most GCAUG contributes to stabilization of the Vamp1 transcript by blocking miR-9 binding. To dissect the roles of this GCAUG and the adjacent miR-9 site, we created a luciferase reporter containing a fragment of the Vamp1 3 0 UTR that includes the last two Rbfox binding sites and the miR-9 site (3 0 F; Figure 2E ). Luciferase expression from this reporter was again dependent on Rbfox1, with a 40% reduction in the cKO neurons compared to wild-type (3 0 F, red bar; Figure 2F ). Similar to the full-length 3 0 UTR, mutating the final GCAUG in this fragment dramatically decreased reporter expression (3 0 Fm7, black bar; Figure 2F ). Conversely, mutation of the miR-9 MRE increased expression in wild-type neurons (3 0 F versus 3 0 FmiR9m, black bars; Figure 2F ) and reduced the effect of Rbfox1 loss in the cKO neurons (3 0 F versus 3 0 FmiR9m, red bars; Figure 2F ). A compound mutation of the miR-9 MRE and both GCAUG elements increased reporter expression relative to mutation of only the 3 0 -most Rbfox site (3 0 Fm7 versus 3 0 Fm6-7miR9m, black bars; Figure 2F ). These results indicate that miR-9 is repressive of Vamp1 expression and that this repression is overcome by RBFOX1 binding. The enhancing effect of the upstream sites indicate that RBFOX binding can also stimulate expression on its own.
To confirm miR-9 targeting of the Vamp1 3 0 UTR, we used AAV to deliver a Tough Decoy (TuD) (Bak et al., 2013; Haraguchi et al., 2009; Xie et al., 2012) containing sequence complementary to the mature miR-9 or a control sequence ( Figure 2G ). We observed $50% reduction of mature miR-9 levels in neurons transduced with the inhibitor (TuD-miR9) compared to control (TuD-ctrl) ( Figure 2G ). We then tested the effect of miR-9 inhibition on the expression of the FL and FLm7 reporters. Suppressing miR-9 in the presence of Rbfox1 did not significantly change expression of the FL reporter, indicating that RBFOX1 binding at the 3 0 end of the UTR efficiently blocks miR-9 activity (FL, black versus orange bars; Figure 2H ). In cKO neurons with this luciferase reporter, inhibition of miR-9 resulted in a visible, though not statistically significant, increase in expression compared to the control TuD (FL, red versus blue bars; Figure 2H ). Notably, the results were different with the FLm7 reporter containing a mutated Rbfox binding site adjacent to the miR-9 MRE. For this construct, inhibition of miR-9 significantly increased reporter expression in the presence of Rbfox1, indicating that loss of the 3 0 most Rbfox binding site renders the reporter responsive to miR-9 (FLm7, orange versus black bars; Figure 2H ). A similar increase in FLm7 expression with miR-9 inhibition was seen in the cKO neurons (FLm7, blue bar; Figure 2H ) but did not reach statistical significance. Overall, these results indicate that RBFOX1 binding to the upstream sites promotes expression independently of miR-9, while the 3 0 -most Rbfox site is blocking the effect of miR-9. (G) Left, schematic of Tough Decoy microRNA inhibitors. Right, quantification of mature miR9 levels by TaqMan assay in neurons transduced with the TuD-miR9 or -control virus. miR9 levels were normalized to the total U6 RNA levels in each sample.
(H) Quantification of FL and FLm7 reporter expression with or without miR9 inhibition. n = 9 cultures (biological replicates). For (D), (F), and (H), Luciferase expression was normalized to Renilla, and the Luc/Ren ratio for each condition was normalized to the wild-type reporter in wild-type neurons (first black bar). Comparisons between other conditions are noted by horizontal bars. Luciferase assays were performed at DIV14. ANOVA with Bonferroni correction; *p % 0.05, **p % 0.01; ***p % 0.001; n.s., not significant; error bars, SEM.
Vamp1 Is Specifically Expressed in Inhibitory Neurons
Vamp1 (Synaptobrevin1/Syb1) is a paralog of the well-studied vSNARE Vamp2 (Synaptobrevin2/Syb2), which is found in both excitatory and inhibitory neurons and is critical for synaptic vesicle docking and neurotransmitter release (Deá k et al., 2006; Schoch et al., 2001) . Although much less characterized, VAMP1 is highly homologous to VAMP2 in protein sequence and domain structure ( Figure 3A) , and several studies have demonstrated that Vamp1 functions similarly to Vamp2 in regulating synaptic vesicle release (Liu et al., 2011; Zimmermann et al., 2014) . We observed that both proteins are expressed in the adult mouse brain, although the onset of VAMP1 expression occurs quite late in development (P15), well after the induction of VAMP2 (E18; Figure 3B ). In primary hippocampal neurons, anti-VAMP1 antibodies yielded the punctate staining pattern expected from a pre-synaptic protein. Virtually all VAMP1 + puncta also contained VAMP2, though only a subset of VAMP2 puncta were positive for VAMP1 ($20% Vamp1 + /Vamp2 + ; Figure 3C ).
The late induction of VAMP1 expression in vivo and its restricted expression in cultured neurons suggested that Vamp1 is specifically expressed in a particular neuronal cell type. Indeed, Vamp1 has been reported to be preferentially expressed at inhibitory synapses (Ferecskó et al., 2015) . To examine Vamp1 expression in neuronal subtypes, we first performed double-label immunocytochemistry of Vamp1 and markers of excitatory and inhibitory neurons in primary hippocampal cultures. Using Gad67 as an inhibitory pre-synaptic marker, we counted all puncta that were VAMP1 + or GAD67 + , or were VAMP1 + /GAD67 + double positive to obtain the total number of puncta. We found that over 80% of the total puncta counted were VAMP1 + /GAD67 + . In a parallel analysis, Vamp1 had virtually no overlap with the excitatory markers Vglut1 and Vglut2 (Figures 4A and 4B) . We observed a similar co-localization with inhibitory markers in sections of adult mouse hippocampi. VAMP1 + puncta were enriched perisomatically in the CA1 and CA3 pyramidal layers (s.p.), and in the dentate granule (DG) layer.
VAMP1
+ puncta were also detected more sparsely in stratum oriens (s.o.) and radiatum (s.r.) of CA1 and CA3, as well as the DG molecular layer and hilus (Figures 4C-4F and S3B-S3E; data not shown). Over 85% of puncta within the CA1 s.p. were VAMP1 + / GAD67 + ( Figures 4C and 4D ). Notably, co-localization was significantly reduced in the Rbfox1 Nes-cKO, where $50% of puncta were now GAD67 + / VAMP1 -. VAMP1 similarly co-localized with GAD67 in s.o. and s.r. ($80%), with a similar reduction in the Rbfox1 Nes-cKO ($30%) ( Figure 4D ). Rbfox1 loss led to a significant reduction in the number of detectable VAMP1 + puncta in all hippocampal regions assayed ( Figure S3A ). Given the reduced VAMP1 levels observed by immunoblot, reduced VAMP1 co-localization with GAD67 in the cKO hippocampus is likely due to a loss of VAMP1 + puncta rather than to mislocalization of the protein. The high level of co-localization between VAMP1 + and GAD67 + puncta confirmed our initial immunocytochemical observations that Vamp1 is expressed specifically in GABAergic inhibitory neurons. VAMP1 co-localization with GAD67 is also consistent with the perisomatic enrichment of VAMP1 + puncta in the pyramidal layers, an innervation pattern typical of Parvalbumin-expressing (PV + ) basket cells . We found that VAMP1 co-localized well with both PV (data not shown) and Synaptotagmin2 (SYT2), a marker of PV + interneuron pre-synaptic terminals (Sommeijer and Levelt, 2012) cells. This consistent with the small number of VAMP1 + / SYT2 -puncta observed in these areas. One potential explanation for the reduction in VAMP1 + puncta is a loss of inhibitory pre-synaptic sites. To address this possibility, we quantified the number of total SYT2 + puncta per square micrometer in adult hippocampal sections to obtain an average Syt2 density. We found no significant difference in Syt2 puncta density in the s.p., s.o., or s.r. of CA1 between wild-type and Rbfox1 Nes-cKO hippocampi ( Figure S5A ), suggesting that the number of PV + pre-synaptic sites was not changed. This result indicated that the loss of VAMP1 + puncta was due to a loss of Vamp1 expression rather than that of inhibitory pre-synaptic sites. We also assessed whether the excitatory or inhibitory synapse density was altered with loss of Rbfox1. Using co-localization of the respective pre-and post-synaptic excitatory markers Synaptophysin and PSD-95 in wild-type and cKO cultured neurons, we found no significant difference in excitatory synapse density ( Figure S5B ). Similarly, using co-localization of pre-synaptic Gad65/67 and post-synaptic Gephyrin, we observed that inhibitory synapse density was also unchanged between the two genotypes ( Figure S5C transmission and in turn contribute to the neuronal hyperexcitation phenotype.
The Rbfox1 Nes-cKO Hippocampus Exhibits Altered Synaptic Transmission To examine whether inhibitory synaptic transmission is affected in the Rbfox1 Nes-cKO brain, we recorded miniature inhibitory (mIPSCs) and excitatory (mEPSCs) post-synaptic currents from CA1 and the DG in acute hippocampal slices from adult (P60-70) Rbfox1 Nes-cKO and wild-type littermates. The average mIPSC and mEPSC peak amplitudes were not significantly different between the two genotypes ( Figures 5B, 5E , 5H, and 5K). While mIPSC amplitudes appeared more variable in the cKO CA1 compared to wild-type (WT) ( Figure 5A ), this difference did not reach statistical significance. Interestingly, we found that the frequency of both mIPSCs and mEPSCs was significantly reduced in both CA1 and the DG ( Figures 5C, 5F , 5I, and 5L). The reduced mIPSC frequency is in concordance with a change in inhibitory synaptic transmission resulting from loss of Vamp1. The decrease in excitatory synaptic transmission is likely due in part to dysregulation of other Rbfox1 targets in excitatory cells (Gehman et al., 2011; Lee et al., 2016) but may also result from a compensatory, homeostatic response to the depletion in Vamp1 (see below). The reduced mIPSC frequency coupled with our finding that inhibitory synaptic density is unaffected in the cKO ( Figure S5 ) are consistent with Vamp1 being an inhibitory-specific pre-synaptic protein with known roles in regulating release probability. We next examined how the reduced frequency of both mIPSCs and mEPSCs might account for the neuronal hyperexcitability and seizures previously observed in the Rbfox1 Nes-cKO brain. To assess the excitation/inhibition (E/I) ratio in synaptic responses elicited by Schaffer collateral stimulation, we recorded synaptic currents in CA1 pyramidal cells voltageclamped at À68 and +10 mV to isolate the respective excitatory AMPAR-mediated and the inhibitory GABA A R-mediated currents ( Figure 5M ). Comparing the peak amplitudes of each component to obtain an E/I ratio, we found that, while both mIPSC and mEPSC frequency are reduced in the Rbfox1 Nes-cKO, the E/I ratio of cKO neurons is increased relative to WT ( Figure 5N ). These results indicate that changes in synaptic transmission, rather than differences in excitatory or inhibitory synapse number, result in skewing of the E/I ratio toward increased excitation in the Rbfox1 Nes-cKO hippocampus, possibly due to the loss of Vamp1 in inhibitory neurons.
Vamp1 Knockdown Reduces Inhibitory Synaptic Transmission
To assay functional changes resulting from the depletion of Vamp1 specifically, we used AAV delivery of short hairpin RNA (shRNA) to knock down Vamp1 in primary hippocampal neurons and measured the amplitude and frequency of mIPSCs and mEPSCs. Compared to the control (shLuc), the Vamp1 knockdown neurons exhibited decreased mIPSC frequency ($50% decrease in shVamp1 compared to shLuc; Figure 6E ) but no changes in amplitude ( Figure 6D ). Importantly, mIPSC frequency was fully restored in the Vamp1 knockdown by co-transduction of a virus expressing an shRNA-resistant Vamp1 driven by the inhibitory neuron-specific mDlx enhancer (Dimidschstein et al., 2016 ) (shVamp1 +mDlx-Vamp1r; Figure 6E ). This re-expressed VAMP1 localized to axons in discrete puncta, similar to the pattern we observed in WT neurons, although the strong expression driven by the mDlx enhancer also led to VAMP1 + puncta in the dendrites ( Figure S6G ). These results confirmed the specificity of our Vamp1 shRNA and indicated that the loss of Vamp1 leads to reduced mIPSC frequency in concordance with its role in inhibitory synaptic transmission. There was no significant change in mEPSC amplitude with Vamp1 knockdown ( Figure 6G ). Interestingly, we also observed a reduction in mEPSC frequency upon Vamp1 knockdown ($50% reduction in shVamp1 compared to shLuc; Figure 6H ), and this could also be rescued by the inhibitory neuron-specific re-expression of Vamp1 (shVamp1 +mDlx-Vamp1r; Figure 6H ). This indicates that the initial reduction in mEPSC frequency upon Vamp1 loss likely resulted from a compensatory, homeostatic change in excitatory synaptic transmission in response to decreased inhibition (Fu et al., 2011; Qiu et al., 2012; Turrigiano, 2011 Figure 7A ). We observed no changes in synaptic transmission between injected and uninjected WT hippocampi ( Figures S7C-S7H ). Inhibitory neuron-specific expression by the mDlx enhancer in vivo was previously demonstrated (Dimidschstein et al., 2016) and confirmed in our experiments by immunohistochemistry. We observed that mDlx-driven tRFP + soma co-localized completely with GAD67 + cells, and that a large subset of these were also PV + ( Figure S7A ). Generating acute slices of control and experimental hippocampi, we recorded mEPSCs and mIPSCs from CA1 across all three injected conditions. Comparing WT and cKO mice injected with control virus, we observed no changes in mEPSC or mIPSC amplitude ( Figures 7D and 7G ) but found a significant reduction in both excitatory and inhibitory current frequency ( Figures 7E and 7H ), similar to our previous observations ( Figure 5 ). Comparing control and Vamp1 rescue cKO samples, we found, remarkably, that re-expression of Vamp1 in Rbfox1 knockout inhibitory neurons could rescue the reduction in mIPSC frequency to levels similar to that of WT ( Figure 7E ). Interestingly, we also observed a rescue of mEPSC frequency with re-expression of Vamp1 in inhibitory neurons ( Figure 7H ). of inhibition (Figure 6 ). These results demonstrate that simply increasing Vamp1 expression is sufficient to rescue the alterations in synaptic transmission observed in the pan-neuronal Rbfox1 Nestin-cKO hippocampus.
Confirming our results in rescuing
DISCUSSION
We have examined how changes in mRNA metabolism controlled by an RBP can alter neurophysiology. Through its interactions with Vamp1, Rbfox1 can specifically regulate inhibitory synaptic transmission. While Rbfox1 is broadly expressed across many neuronal cell types, inhibitory neuron dependence on Vamp1 function renders this neuronal population susceptible to Rbfox1 loss. This work demonstrates how the dysregulation of a broadly expressed RBP can result in defects in specific neuronal subtypes leading to altered neural circuit function. (G and H) Quantification of average mEPSC amplitude and frequency shows re-expression of mDlx-driven Vamp1 also rescues mEPSC frequency to levels similar to that of wild-type. Number of cells recorded per condition across 6 littermate pairs is shown above bars. One-way ANOVA with Bonferroni correction; *p % 0.05; error bars, SEM. See also Figure S7 . Xue et al., 2016) . Although both are broadly expressed across multiple neuronal cell types and brain regions, our work defines roles for Rbfox1 and miR-9 in modulating the expression of Vamp1 specifically in inhibitory neurons. It will be interesting to further characterize the overlap in the Rbfox1 and miR-9 regulatory networks and to understand the role of these opposing regulators in the function of other neuronal cell types and circuits.
The specific expression of Vamp1 in inhibitory neurons of the hippocampus and cortex indicates that these cells maintain a specific machinery for inhibitory synaptic transmission. Unlike excitatory neurons, which express only Vamp2, inhibitory neurons express both Vamp1 and Vamp2 ( Figure 3C ). Co-expression of Vamp1 and Vamp2 has also been observed at the neuromuscular junction (NMJ). Work examining NMJ function in a Vamp1 hypomorphic mouse (lew/lew) (Nystuen et al., 2007) showed that loss of Vamp1 in motor neurons reduced the Ca 2+ sensitivity and cooperativity of synaptic transmission. Vamp1 loss did not abolish neurotransmitter release, but reduced release probability, thus increasing the variability of the post-synaptic response (Liu et al., 2011) . Like the NMJ, inhibitory synapses exhibit high neurotransmitter release probability in response to excitatory signaling (Atallah and Scanziani, 2009; Pouille and Scanziani, 2001 ). Inhibitory neurons, in particular, fast spiking PV + basket cells, play a pivotal role in the generation of cortical and hippocampal network oscillations through the precise control of principal cell firing (Bartos et al., 2007; Buzsá ki and Wang, 2012; Cardin et al., 2009 ). These oscillations require the fast and precise conversion of excitatory input into inhibitory neurotransmitter release in PV + interneurons (Atallah and Scanziani, 2009; Hu et al., 2014; Jonas et al., 2004; Pouille and Scanziani, 2001) . Although not statistically significant, we did observe an increase in mIPSC amplitude variability in the cKO hippocampus that may stem from reduced levels of Vamp1. Similar to its action in motor neurons, Vamp1 may increase release probability in the PV + neurons of the CNS and ensure the reliability of inhibitory synaptic transmission.
A dynamic interplay between Rbfox1 and miR-9 may serve to fine-tune inhibitory synaptic transmission during physiologically relevant states such as learning and memory. Gamma oscillations in the hippocampus driven by the precisely timed firing of PV + interneurons have been proposed to function in working memory, spatial processing, and coordination across brain structures (Buzsá ki and Wang, 2012; Colgin et al., 2009; Lisman and Jensen, 2013; Yamamoto et al., 2014) . Vamp1 regulation may also be important in the cortical processing of sensory input, which relies on fast spiking PV + cells to distinguish preferred stimuli, recruit specific principal cell populations, and modulate sensitivity to stimuli. (Hu et al., 2014; Isaacson and Scanziani, 2011; Tremblay et al., 2016; Xue et al., 2014) . Dynamic changes in Vamp1 levels could alter the window of input integration in feedforward circuits or change the population of excitatory neurons recruited in response to different stimuli.
Rbfox1 Regulation of E/I Balance and Implications in Neurologic Disease
Mutation and/or dysregulation of RBFOX1 has been implicated in epilepsy and ASD. Rbfox1/RBFOX1 was identified as a candidate ASD susceptibility gene (Bhalla et al., 2004; Bill et al., 2013; Martin et al., 2007; Sebat et al., 2007; Voineagu et al., 2011) , and changes in both Rbfox1-mediated gene expression and alternative splicing Voineagu et al., 2011; Weyn-Vanhentenryck et al., 2014) have been observed in ASD patient brains. Recent work found that cytoplasmic Rbfox1 targets, including Vamp1, showed significant overlap with genes involved in ASD . Mutations in RBFOX1 and RBFOX3 are also potential risk factors in a range of epileptic disorders (Lal et al., 2013a (Lal et al., , 2013b (Lal et al., , 2015 . E/I balance and altered network oscillations are thought to be dysregulated in ASD (Gogolla et al., 2009; Hammer et al., 2015; Jurgensen and Castillo, 2015; Lee et al., 2015; Nakamura et al., 2015; Pizzarelli and Cherubini, 2011; Uhlhaas and Singer, 2006; van de Lagemaat et al., 2014; Yizhar et al., 2011) and epilepsy (Fritschy, 2008; Lee et al., 2015; Peñ agarikano et al., 2011) . In one study, using optogenetic tools to increase the E/I ratio led to ASD-like impairments in social and cognitive function in mice and to changes in baseline gamma oscillations (Yizhar et al., 2011) . Our finding that Vamp1 expression in inhibitory neurons rescues not only inhibitory but also excitatory synaptic transmission indicates that reduced Vamp1 expression is a major component of the E/I imbalance seen in response to the Rbfox1 mutation. Changes in Rbfox1 function may thus underlie the changes in inhibitory signaling and E/I balance associated with these diseases (Marín, 2012) .
Individual Neuronal Cell Types Exhibit Specific Susceptibilities to Rbfox1 Loss
Although the Rbfox proteins are co-expressed in many neuronal cell types, their functions are not redundant. The proteins are highly homologous and exhibit similar binding activities in vivo Weyn-Vanhentenryck et al., 2014) and similar splicing regulatory activities in vitro Underwood et al., 2005) . However, the different phenotypes of the Rbfox1 and Rbfox2 knockout mice have hinted at the particular susceptibility of neuronal subpopulations to the loss of individual Rbfox paralogs (see also Figures S2 and S4 ). While our RNA-seq data revealed targets affecting both excitatory and inhibitory synapses, the shift in E/I ratio toward increased excitation, and the similarity of the Vamp1 depletion phenotype to that of the Rbfox1 Nes-cKO, indicate a greater effect on inhibitory signaling. Indeed, we find that the transcripts downregulated by Rbfox1 loss are enriched for genes whose expression correlates with the expression of inhibitory neuron markers, while transcripts that increase in the cKO were enriched for genes associated with excitatory neuron marker expression (Kang et al., 2011) (Figure S1B ). Similar to our findings that Vamp1 is specific to inhibitory neurons and is strongly downregulated by Rbfox1 loss, this analysis emphasizes how RBPs can function in distinct ways in different cell types. Rather than a general Rbfox regulatory program common to all neurons, neuronal subtypes have their own programs of posttranscriptional regulation leading to cell-typespecific patterns of gene expression. The regulation of inhibitory neuron-specific Vamp1 by Rbfox1 provides a paradigm for how other broadly expressed RBPs may perform crucial functions in defined neuronal populations. There are many families of RNA-binding proteins that are expressed across multiple neuronal populations, and the consequences of RBP loss have mostly been studied after pan-neuronal or germline deletion. Similarly, RNA-seq and CLIP-seq analyses of these RBPs have identified their targets in whole-brain or mixed tissue samples. Our results indicate that examination of these other RNA regulators in specific cell types (Hwang et al., 2017) should yield important new understanding of their functions.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: ) animals. For RNA-seq, qPCR and immunoblot experiments, male littermates were sacrificed between P60 and P70 by CO 2 overdose followed by cervical dislocation. For immunohistochemistry, P60-P70 male littermates were anesthetized with a mixture of 100mg/kg Ketamine and 10mg/kg Xylazine, followed by transcardial perfusion with ice-cold 1x PBS and 4% paraformaldehyde in 1x PBS. For electrophysiology experiments, P60-P70 male littermates were deeply anesthetized with isoflurane and sacrificed by decapitation. Stereotaxic injections were performed on P60-P70 male littermates and are further described below.
Primary Neuronal Culture
Embryonic day 16-18 C57BL/6J pregnant dams (Charles River Laboratories) were sacrificed by CO 2 overdose followed by cervical dislocation. Embryos were decapitated with sharp scissors, and hippocampi from males and females were dissected out into ice-cold Hank's Balanced Salt Solution (HBSS, Ca 2+ -and Mg 2+ -free) and randomly pooled. Hippocampi were trypsinized in a 37 C water bath for 10 min and mechanically dissociated, and cells were plated at a density of $790 cells/mm 2 (for RNA or protein isolation) or 395 cells/mm 2 (for immunocytochemistry) on tissue culture-treated plates or nitric-acid treated glass coverslips coated with 0.1mg/mL poly-DL-lysine (Sigma-Aldrich) in 0.1M boric acid, pH 8.5. Cells were initially plated in Neurobasal (GIBCO) based Plating Media containing B27 (GIBCO), Glutamax (GIBCO), 25mM glutamate and 25mM B-mercaptoethanol and subsequently fed with Neurobasal based Feeding Media containing B27 and Glutamax every 3 days beginning at 3 days in vitro (DIV3). Primary cultures were maintained in a 37 C incubator supplemented with 5% CO 2 .
Heterologous Cell Culture 293T (female) and 293FT (female) cells were grown in Dulbecco's Modification of Eagle's Medium (DMEM, Corning MT-10-017-CV) with L-glutamine and 4.5g/L glucose, supplemented with 10% fetal bovine serum and penicillin-streptomycin, and maintained in a 37 C incubator with 5% CO 2 . For transfection, cells were plated on poly-ornithine coated plates, grown to 60%-70% confluency and transfected with indicated plasmids using Lipofectamine 2000 (Invitrogen) for 6 hr. Live 293T cells were visualized on a Nikon TE2000-S inverted microscope and imaged using a SPOT RT-KE 7.4 slider CCD camera (Diagnostic instruments), or lysed in RIPA buffer for protein isolation 48 hr post-transfection. 293FT cells transfected for AAV production were processed as described below. All cell lines tested negative for mycoplasma contamination, but have not been further authenticated.
METHOD DETAILS Electrophysiology
Slice Preparation
Mice were deeply anesthetized with isoflurane and following decapitation the brain was rapidly removed and placed into ice-cold N-Methyl-D-Glucamine (NMDG)-based cutting solution containing (in mM): 135 NMDG, 10 D-glucose, 4 MgCl 2 , 0.5 CaCl 2 , 1 KCl, 1.2 KH 2 PO 4 , and 26 HEPES (pH = 7.3-7.4, 290-300 mOsm/L), bubbled with 100% O 2 . Coronal slices (320 mm) were prepared using a Campden 7000SMZ-2 Vibratome and then maintained in an interface-slice type chamber continuously perfused (2-3 mL/min) with a warm (30 C), oxygenated (95% O 2 /5% CO 2 ) artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 2.4 KCl, 25 NaHCO 3 , 1 NaH 2 PO 4 , 2 CaCl 2 , 1.2 MgSO 4 , and 10 glucose (pH 7.4, 290-300 mOsm). Slices were allowed to recover for at least 1 hr prior to recordings. All experimental techniques were approved by the Institutional Animal Care and Use Committee at the University of California, Los Angeles.
Patch-Clamp Recordings in Brain Slices and Cultured Neurons
Slices were transferred to a submerged-slice recording chamber continuously perfused (3 mL/min) with ACSF and whole-cell voltage-clamp techniques were used to record both evoked and miniature EPSCs and IPSCs. CA1 pyramidal cells and dentate gyrus granule cells were visualized using an IR-DIC upright microscope (Zeiss Examiner D1) and whole-cell recordings were performed using borosilicate patch electrodes (4-6 MU), containing (in mM): 120 CsMeSO 4 , 10 CsCl, 5 TEA-Cl, 1.5 MgCl 2 , 10 HEPES, 0.1 EGTA, 2 Na-ATP, 0.5 Na-GTP, and 5 QX-314, pH 7.25-7.30 with CsOH, 275-285 mOsm. Recordings were obtained using a MultiClamp 700B amplifier with Digidata 1440A and pClamp 10 (Molecular Devices). Series resistance and whole-cell capacitance were automatically compensated and recordings were discontinued if series resistance increased by >20%. A bipolar, tungsten wire stimulating electrode placed in stratum radiatum proximal to the CA3 region was used to activate Schaffer collateral/commissural fibers and elicit EPSCs and IPSCs in CA1 pyramidal cells (stimulation rate = 0.05 Hz). In these experiments, we isolated the excitatory and inhibitory components of the evoked responses by recording synaptic currents at holding potentials (V hold ) of À68 and +10 mV, respectively. Bath application of 20 mM CNQX and 50 mM APV blocked synaptic currents at V hold = À68 mV while application of 100 mM picrotoxin blocked synaptic currents at V hold = +10 mV, confirming that EPSCs and IPSCs are isolated at these membrane potentials (data not shown). The intensity of presynaptic fiber stimulation was adjusted to elicit EPSCs with a peak amplitude of 100-300 pA at V hold = À68 mV, and with the same stimulating intensity to record IPSCs at V hold = +10 mV. Miniature EPSCs and IPSCs were recorded in the presence of 1 mM TTX. In experiments recording EPSCs and IPSCs in cultured neurons, cells were bathed in an external solution containing (in mM): 140 NaCl, 3 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 D-glucose, 26 HEPES, and 1 mM TTX (pH = 7.4, 290-300 mOsm/L). Data Analysis and Chemicals Evoked currents were analyzed in Clampfit 10, and amplitude was measured as the peak of currents. Miniature E/IPSCs were detected and analyzed with custom-written LabView-based software. All results are presented as mean ± SEM. Statistical significance was determined using unpaired t tests. Picrotoxin and TTX were purchased from Tocris Biosciences. All other chemicals were from Sigma-Aldrich.
Stereotaxic Injections
Adult (P60-P70) male littermates were anesthetized with 5% isoflurane and 33% N 2 O mixed with O 2 . Hair on the head was shaved following anesthesia, and animals were given 0.1mg/kg buprenorphine via intraperitoneal injection. Animals were fitted to a stereotaxic frame with blunt ear bars and provided with the same anesthesia mixture for the duration of the surgery. Skin on the head was sterilized with 70% ethanol and 10% povidone iodine, and an incision in the skin was made followed by craniotomies 2-3mm in diameter above the left and right hippocampi at À2.0mm posterior to Bregma and ± 1.5mm lateral to the midline. A glass micropipette driven by a syringe pump was used to deliver 3.9 E+12 genome copies ($1mL) of AAV2/9 mDlx-tRFP or AAV2/9 mDlx-tRFP-p2A-Vamp1r to CA1 at a depth of À1.6mm relative to the pial surface, at a rate of 0.2uL/min. The pipette was left in place for 6 min after injection and withdrawn slowly over a 5-min interval. The surgical incision was closed with external nylon sutures. Animals recovered in their home cages and were given intraperitoneal 0.1mg/kg buprenorphine twice daily for 3 days afterward. Animals were sacrificed three weeks post-injection for electrophysiology or transcardially perfused for immunohistochemistry.
RNA Sequencing
Three pairs of P60-P70 Rbfox1 Nes-cKO and WT male littermates from different litters were sacrificed and hippocampi were dissected out in ice-cold HBSS. Hippocampi were lysed in Trizol (Invitrogen) using a Tissue Tearor and RNA was extracted according to the manufacturer's instructions. 1ug of total RNA was used for polyA selection and library construction using the Tru-Seq mRNA Stranded Library Kit (Illumina). Isolated PolyA-plus RNA was converted to cDNA and subjected to 50 nt paired-end sequencing using the standard Illumina platform on a Hi-Seq 2000.
Quantitative PCR
Relative Gene Expression Trizol-extracted RNA was subjected to DNase treatment (DNaseI, Roche) and purified by acidic phenol-chloroform extraction. 1ug of total RNA and oligo(dT) 18 primers were used for reverse transcription by Superscript III (Invitrogen), and equal volumes of cDNA across samples were used for qPCR using the SensiFAST SYBR Lo-ROX qPCR mix in a QuantStudio6 (Applied Biosystems). All relative fold change quantifications were normalized to expression of the housekeeping gene, Hprt. Absolute Quantitation DNase-treated RNA was extracted and reverse transcribed as described above. For spliced and unspliced Vamp1 transcripts, cDNA from brain samples was quantified against a standard curve of 10-fold dilutions of spliced or unspliced products ranging from 10 3 -10 8 nM. For quantitation of AAV titer, an aliquot of the virus was treated with DNase, followed by DNase inhibition and Proteinase K treatment to release the viral genome. Viral genomes were quantified against a standard curve of the cognate AAV genome plasmid ranging from 5x10 1 -5x10 8 copies/mL to obtain a titer of genome copies (GC) per mL. Taqman Assay DNase-treated RNA was extracted as described above, and 10ng of total RNA was used for reverse transcription (RT) using the Multiscribe Reverse Transcriptase (ThermoFisher) and primers specific to the mature mmu-miR-9 or, as a control, U6 snRNA. The RT product was then amplified using fluorescent Taqman-MGB probes specific for miR-9 or U6. Relative fold changes in miR-9 levels were normalized to U6.
DNA Constructs and Adeno-Associated Viruses
Luciferase Reporters pGL3-control (Promega) was used to insert the full length (FL) or a portion (3 0 F) of the Vamp1 3 0 UTR following the Luciferase gene using the NdeI and FseI restriction sites. Mutations of Rbfox binding sites in the 3 0 UTR from (U)GCAUG to (U)GACGU and of the miR9 seed site from CCAAAG to GGUUAG were created using site-directed mutagenesis and subcloned into pGL3-control.
RNAi Constructs
The pAAV-U6-shLuc-CMV-GFP plasmid was used as a backbone to insert a hairpin targeting the Vamp1 coding sequence (5 0 -GAGC AGTGCTGCCAAGCTAAA-3 0 ) using the BamHI and EcoRI restriction sites.
Vamp Expression Constructs
The Vamp1 coding sequence (NM_009496.3) was generated as a gBlock (IDT) along with p2A-tRFP and cloned into pcDNA3.1(+) using BamHI and EcoRI, or into pAAV-hSyn-Cre-WPRE-hGH (University of Pennsylvania Vector Core Facility #PL-C-PV1969) using AgeI and EcoRI. The Vamp2 construct in pcDNA3.1(+) was similarly created using the Vamp2 coding sequence (NM_009497.3).
A tRFP-p2A-Vamp1r RNAi-resistant gBlock containing silent mutations within the shRNA targeting region was cloned into pcDNA3.1(+) and pAAV-hSyn-Cre-WPRE-hGH using the same restriction sites as above to create rescue constructs. The pAAVmDlx-GFP-Fishell-1 plasmid (Addgene #83900) was used as a backbone to insert either tRFP or tRFP-p2A-Vamp1r using the SpeI and AscI restriction sites to create pAAV-mDlx-tRFP and pAAV-mDlx-tRFP-p2A-Vamp1r. Tough Decoy Constructs Tough decoy sequences were designed according to (Haraguchi et al., 2009 ; Figure 2 ). The mature miR-9 targeting sequence is 5 0 -CTCATACAGCTAATCTGATAACCAAAGA-3 0 , and the control sequence is 5 0 -CGCGACTATACGATCTCGCAATATGGT-3 0 , where the ATCT is not complementary to the mature miR sequence and produces a bulge. The control TuD sequence was obtained from a negative control sequence for mouse as validated by IDT (IDT miRNA Inhibitors). Synthetic oligos of TuD stem loops containing the mature miR-9 or control sequence were annealed and inserted into pAAV-U6-shLuc-CMV-eGFP-SV40 (University of Pennsylvania Vector Core Facility # PL-C-PV1867) using the BamHI and EcoRI sites. CMV-eGFP was replaced with hSyn-tRFP using XbaI and NotI. Adeno-Associated Viruses All AAV were packaged with capsid serotype 9. AAV2/9 mDlx-tRFP, mDlx-tRFP-p2A-Vamp1r, U6-TuDctrl-hSyn-tRFP and U6-TuDmiR9-hSyn-tRFP were produced by co-transfection of the AAV2 genomic plasmid, pHelper and an AAV9 envelope plasmid into 293FT cells. Viral particles were obtained from the cell pellet and media at 3 and 5 days posttransfection by polyethyleneglycol (PEG) precipitation, purified using an ioxodianol gradient and concentrated using an Amicon centrifugal filter with a 100kDa membrane. Viral titer was determined by qPCR using a standard curve of the genome plasmid. AAV2/9 hSyn-Rbfox1-cytoplasmic was previously described [hSyn.Flag-Rbfox1_c_siMt] , and U6-Vamp1sh#5-CMV-GFP and U6-shLuc-CMV-GFP viruses were generated at the University of Pennsylvania Vector Core Facility. AAV2/9 hSyn-eGFP and AAV2/9 hSyn-Cre-eGFP viruses were also purchased from the University of Pennsylvania Vector Core Facility.
with 10% goat serum in 0.5% Triton/PBS for 1 hr at room temperature. Sections were incubated with primary antibodies overnight at 4 C, followed by 3 washes and secondary antibody incubation for 2 hr at room temperature. Antibodies were diluted in 3% BSA with 0.02% sodium azide in 0.5% Triton/PBS. Sections were mounted in ProLong Gold and imaged using 10x, 20x air or 40x, 63x oil objectives as indicated in each figure legend on Zeiss LSM 510 Meta and LSM 780 confocal microscopes.
The following antibodies were used: ms a-Rbfox1 clone 1D10 (EMD Millipore), 1:2000; rb a-Vamp1, 1:1000 (Synaptic Systems); gp a-Vamp2, 1:1000 (Synaptic Systems); ms a-Gad67 clone 1G10.2, 1:1000 (EMD-Millipore); rb a-Gephyrin, 1:1000 (Synaptic Systems); ch a-Map2, 1:2000 (Abcam); ms a-PSD-95, 1:1000 (Antibodies Incorporated); gp a-Synaptophysin, 1:1000 (Synaptic Systems); ms a-znp-1 (Synaptotagmin2), 1:1000 (ZIRC); gp a-Parvalbumin, 1:1000 (Synaptic Systems). Alexa Fluor 488-, 568-or 647-conjugated goat a -mouse, -rabbit, -chicken or -guinea pig secondary antibodies (Thermo Fisher) were used at a dilution of 1:1000 for 488 and 568, and 1:500 for 647.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantitative data are presented as mean ± SEM. All experiments were independently repeated at least three times. See figure legends for statistical details and significance of each experiment.
Quantification of Pre-synaptic Puncta All quantification was done by hand in ImageJ (Schneider et al., 2012) . Cultured neurons used for quantification were imaged at 63x magnification. For VAMP1 co-localization with excitatory or inhibitory markers ( Figures 3A and 3B ), puncta were counted within 100mm 2 areas in a total of 15 images from 1 culture (biological replicate). For co-localization of excitatory or inhibitory pre-and postsynaptic puncta ( Figures S5B and S5C ), puncta were counted along 3-4 50mm dendritic sections per image, from 5-6 images per culture, in 3-4 cultures (biological replicates). Tissue sections used for quantification were imaged at 40x magnification. For VAMP1 puncta co-localization with GAD67 or SYT2 in CA1 (Figures 3C-3F ), puncta were counted within at least (3) 50mm 2 areas/image, in a total of 3 images per animal (n = 3 animals). For VAMP1 puncta co-localization with GAD67 or SYT2 in DG ( Figures S3B-S3E ), puncta were counted within at least 2 (DG hilus) or 3 (DG sp and ip) 50mm 2 fields/image, in a total of 1 (DG hilus) or 2 (DG sp and ip) images per animal (n = 3 animals).
RNA-Seq Analysis
An average of 48 million reads were generated per replicate sample. Reads were aligned to the mouse genome (mm9) using TopHat version 2.0.10 (Trapnell et al., 2012) with an average mapping rate of 90%. Spliced isoform analysis was done using SpliceTrap version 0.92 (Table S1 ) (Wu et al., 2011) . Events with changes in percent spliced in jdelta PSIj > 10% and read coverage exon 1 > 50 and exon 3 > 50 in both samples were considered significant. Overall expression levels were detected using the Cufflinks package version 2.2.1 (Table S2 ) (Trapnell et al., 2012) . For differential gene expression, q < 0.05 and log2 fold-change R 1.2 was used to define significant changes.
Enrichment Analysis in Specific Cell Subtypes
Logistic regression was used to assess enrichment of Rbfox1-regulated transcripts in inhibitory and excitatory cell subtypes (Figure S1B) . ''Enriched genes'' are those with an FDR adjusted p < 0.05 for the respective cell type. Cell-specific gene lists encompass the top 100 genes correlated to canonical markers of specific subtypes of inhibitory and excitatory cell types in a spatiotemporal atlas of human brain expression (Kang et al., 2011) .
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE96722.
